Alvotech Files Routine 6-K with SEC
Ticker: ALVOW · Form: 6-K · Filed: Jun 11, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, routine-disclosure
TL;DR
Alvotech filed a 6-K, just a routine update, nothing major to see here.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on June 11, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events but serves as a routine update to the SEC.
Why It Matters
This filing indicates Alvotech is fulfilling its reporting obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges but incorporated elsewhere.
Risk Assessment
Risk Level: low — The filing is a standard Form 6-K, which typically contains routine disclosures and does not present new material risks.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 241034647 (company) — Film Number
- 9, Rue de Bitbourg, L-1273 Luxembourg (company) — Principal Executive Office Address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is Alvotech.
What is the Commission File Number for Alvotech?
The Commission File Number is 001-41421.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Does Alvotech file annual reports under Form 20-F or 40-F?
Alvotech indicates it files annual reports under Form 20-F.
Filing Stats: 367 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2024-06-11 08:27:42
Filing Documents
- f6k_061024.htm (6-K) — 8KB
- exh_991.htm (EX-99.1) — 15KB
- 0001171843-24-003383.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: June 11, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel